Abstract: . . .  www.ipej.org 305 Review Article Atrial Fibrillation and Hyperthyroidism This paper has also been published in the ISHNE AF World-Wide Internet Symposium Jayaprasad N, MBBS, MD; Johnson Francis, MBBS, MD, DM. Department of Cardiology, . . .
. . .  www.ipej.org 305 Review Article Atrial Fibrillation and Hyperthyroidism This paper has also been published in the ISHNE AF World-Wide Internet Symposium Jayaprasad N, MBBS, MD; Johnson Francis, MBBS, MD, DM. Department of Cardiology, Medical . . .
. . .  Sakurai K, Hamada N, Momotani N, Ito K. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 1982;72: 903-6. 37. Fierro N, Gonnella C, Pietropaolo L, Morelli A, Di Cola G, D'Ermo G, Galassi G Jr, Galassi G. Atrial fibrillation and hyperthyroidism: results after thyroidectomy. G Chir. 2002;23(11-12): 431-3. 38. Koutras D . Subclinical hyperthyroidism. Thyroid .1999; 9:311315 39. Toft AD. Clinical practice. Subclinical hyperthyroidism. . . .
. . .  K, Hamada N, Momotani N, Ito K. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 1982;72: 903-6. 37. Fierro N, Gonnella C, Pietropaolo L, Morelli A, Di Cola G, D'Ermo G, Galassi G Jr, Galassi G. Atrial fibrillation and hyperthyroidism: results after thyroidectomy. G Chir. 2002;23(11-12): 431-3. 38. Koutras D . Subclinical hyperthyroidism. Thyroid .1999; 9:311315 39. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl . . .
. . .  Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin- suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab .2000;85:159164. Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(4): 305-311 (2005)  . . .
. . .  9:311315 39. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med . 2001; 345:512516. 40. Sgarbi JA, Villaca FG, Garbeline B, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metab. 2003 Apr;88(4):1672-7. 41. Biondi B, Fazio S, Carella C, Sabatini D, Amato G, Cittadini A, Bellastella A, Lombardi G, Sacca L. Control of adrenergic overactivity . . .
--3000,6,250,2874,26986